Vivo Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 17-06-2024
- Paid Up Capital ₹ 2.67 Cr
as on 17-06-2024
- Company Age 14 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.50 Cr
as on 17-06-2024
- Satisfied Charges ₹ 1.13 Cr
as on 17-06-2024
- Revenue 23.91%
(FY 2023)
- Profit -58.28%
(FY 2023)
- Ebitda -24.56%
(FY 2023)
- Net Worth 5.13%
(FY 2023)
- Total Assets -6.76%
(FY 2023)
About Vivo Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 2.67 Cr.
The company currently has active open charges totaling ₹1.50 Cr. The company has closed loans amounting to ₹1.13 Cr, as per Ministry of Corporate Affairs (MCA) records.
Nischhal Sharma, Anil Sharma, and Anuradha Sharma serve as directors at the Company.
- CIN/LLPIN
U24233TG2010PTC071007
- Company No.
071007
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Oct 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Tirumalagiri, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Vivo Life Sciences Private Limited offer?
Vivo Life Sciences Private Limited offers a wide range of products and services, including Career Guidance & Admission Services, Educational Services.
Who are the key members and board of directors at Vivo Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Sharma  | Managing Director | 28-Oct-2010 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nischhal Sharma | Director | 19-Aug-2021 | Current |
| Anuradha Sharma | Director | 29-Nov-2018 | Current |
Financial Performance of Vivo Life Sciences.
Vivo Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 23.91% increase. The company also saw a substantial fall in profitability, with a 58.28% decrease in profit. The company's net worth moved up by a moderate rise of 5.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vivo Life Sciences?
In 2023, Vivo Life Sciences had a promoter holding of 82.98% and a public holding of 17.02%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 17 May 2022 | ₹1.50 Cr | Open |
Others Creation Date: 06 Aug 2018 | ₹1.13 Cr | Satisfied |
How Many Employees Work at Vivo Life Sciences?
Unlock and access historical data on people associated with Vivo Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vivo Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vivo Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
